Profile data is unavailable for this security.
About the company
CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally engaged in discovering, developing and commercializing innovative chimeric antigen receptor (CAR)-T cell therapies. The Company’s therapies are applied in the treatment of hematological malignancies and solid tumors. The Company have developed an upgraded B cell maturation antigen (BCMA) targeted CAR-T product, CT053, which is its sole core product candidate. The Company conducts its businesses in China and the United States.
- Revenue in HKD (TTM)0.00
- Net income in HKD-802.64m
- Incorporated--
- Employees516.00
- LocationCARsgen Therapeutics Holdings LtdBuilding 12No.388 Yindu Road, Xuhui DistrictSHANGHAI KY1-1205ChinaCHN
- Websitehttps://www.carsgen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jacobio Pharmaceuticals Group Co Ltd | 68.18m | -385.46m | 1.32bn | 301.00 | -- | 1.15 | -- | 19.34 | -0.4986 | -0.4986 | 0.0882 | 1.46 | 0.0419 | -- | 5.21 | 226,508.40 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
Hua Medicine | 82.23m | -226.73m | 1.38bn | 177.00 | -- | 11.83 | -- | 16.82 | -0.232 | -0.232 | 0.0842 | 0.1107 | 0.0538 | 1.69 | 13.03 | 464,571.50 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Wuhan YZY Biopharma Co Ltd | 0.00 | -205.76m | 1.45bn | 123.00 | -- | 10.57 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7068 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
Mabpharm Ltd | 93.55m | -224.71m | 1.48bn | 347.00 | -- | 6.75 | -- | 15.87 | -0.0545 | -0.0545 | 0.0227 | 0.0534 | 0.0893 | 0.1176 | 6.02 | 269,608.20 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
TOT Biopharm International Co Ltd | 837.89m | -40.53m | 1.51bn | 551.00 | -- | 2.06 | 289.65 | 1.81 | -0.0559 | -0.0559 | 1.16 | 0.9538 | 0.5808 | 1.87 | 8.03 | 1,520,665.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
CStone Pharmaceuticals | 497.86m | -394.17m | 1.55bn | 230.00 | -- | 3.17 | -- | 3.12 | -0.3125 | -0.3125 | 0.3942 | 0.3818 | 0.2811 | 2.44 | 3.72 | 2,164,625.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Immunotech Biopharm Ltd | 0.00 | -359.38m | 1.57bn | 211.00 | -- | 8.45 | -- | -- | -0.6984 | -0.6984 | 0.00 | 0.3621 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
Frontage Holdings Corp | 2.03bn | 84.38m | 1.59bn | 1.76k | 19.10 | 0.5933 | 4.39 | 0.7827 | 0.0408 | 0.0408 | 0.9802 | 1.31 | 0.463 | 60.63 | 5.32 | 1,153,334.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Laekna Inc | 0.00 | -395.87m | 1.65bn | 89.00 | -- | 1.91 | -- | -- | -3.28 | -3.28 | 0.00 | 2.21 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
Abbisko Cayman Ltd | 20.46m | -463.24m | 2.09bn | 258.00 | -- | 1.00 | -- | 101.99 | -0.7157 | -0.7157 | 0.0316 | 3.03 | 0.0083 | -- | 1.40 | 79,294.59 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
Alphamab Oncology | 234.82m | -226.04m | 2.13bn | 435.00 | -- | 1.19 | -- | 9.08 | -0.2351 | -0.2351 | 0.2446 | 1.86 | 0.1028 | 0.7705 | 19.34 | 539,817.30 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
CARsgen Therapeutics Holdings Ltd | 0.00 | -802.64m | 2.54bn | 516.00 | -- | 1.31 | -- | -- | -1.44 | -1.44 | 0.00 | 3.36 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 769.50m | -411.04m | 2.95bn | 1.07k | -- | 3.50 | -- | 3.84 | -1.03 | -1.03 | 1.93 | 2.11 | 0.2732 | 16.21 | 5.74 | 721,853.40 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Data as of Jul 24 2024. Currency figures normalised to CARsgen Therapeutics Holdings Ltd's reporting currency: Hong Kong Dollar HKD
12.49%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Aegon-Industrial Fund Management Co., Ltd.as of 31 Dec 2023 | 24.85m | 4.32% |
The Vanguard Group, Inc.as of 04 Jul 2024 | 13.96m | 2.43% |
HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 8.59m | 1.49% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 7.61m | 1.32% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 6.20m | 1.08% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 3.02m | 0.53% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 2.67m | 0.46% |
Fullgoal Asset Management (HK) Ltd.as of 30 Jun 2023 | 1.91m | 0.33% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.70m | 0.30% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 1.39m | 0.24% |
More ▼
Data from 30 Jun 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.